Lupin gets USFDA nod for 5mg, 10mg, 20mg and 40mg Rosuvastat
Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...
Drug firm Lupin has received final approval from the USFDA to market its Rosuvastatin Calcium tablets in the strengths of 5 mg, 10 mg, 20 mg and 40 mg used for the treatment of adult patients with hypertriglyceridemia, primary dysbetalipoproteinemia and patients with homozygous familial hypercholesterolemia. The product is a generic version of iPR Pharmaceuticals Inc’s Crestor tablets.



http://www.thehindubusinessline.com/companies/lupin-gets-usfda-nod-for-cholesterollowering-drug/article9800465.ece
Preview
1 share
Like
Comment
Share